Evolus to Participate in The Needham 24th Annual Virtual Healthcare Conference

NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced that members of its management team will participate in a fireside chat and investor meetings at the upcoming Needham Annual Virtual Healthcare Conference. The fireside chat will take place on Tuesday, April 8, 2025, at 12:45 PM ET - Track 1. The fireside chats can be accessed on the Investor Relations page of the Evolus website here . A replay of the webcast will be available for 90 days after the date of each presentation. About Evolus, Inc. Evolus (NASDAQ: EOLS) is a global performance beauty company redefining the aesthetic injectable market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global leader in aesthetics anchored by our flagship products: Jeuveau ® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics, and Evolysse ™ , a collection of unique injectable hyaluronic acid (HA) gels. Visit us at www.evolus.com , and follow us on LinkedIn , X , Instagram or Facebook . Jeuveau ® and Nuceiva ® , are registered trademarks and Evolysse ™ is a trademark of Evolus, Inc. Contacts Investors: Nareg Sagherian, Vice President, Head of Global Investor Relations and Corporate Communications Phone: (248) 202-9267 Email: ir@evolus.com Media : Email: media@evolus.com